James Buchanan Brady Urological Institute #2 in the Nation According to U.S. News and World Report’s 2019-20 rankings.
Eugene Fuller Triennial Prostate Award
Dr. Carter, Professor of Urology and Oncology, is an internationally recognized expert in the diagnosis and treatment of prostate cancer.
Dr. Carter trained in urological surgery at The New York Hospital-Cornell Medical Center and completed a fellowship in urological oncology at the Brady Urological Institute at Johns Hopkins. In 1989, he joined the Johns Hopkins Medicine faculty as an assistant professor of urology, was promoted to associate professor in 1993, and full professor of urology and oncology in 1998.
Dr. Carter’s career has been focused on promoting a balanced approach to prostate cancer diagnosis and treatment. Although trained as a surgeon, he has been a voice of reason emphasizing the public health concerns of over diagnosis and over treatment of prostate cancer. Dr. Carter’s research interests and academic involvement have been directed toward reducing the harms of prostate cancer screening by improving screening practices. He led the American Urological Association Guideline Panel for the Diagnosis of Prostate Cancer that developed the first urological guidelines for prostate cancer screening. His development of a program in 1995 at Johns Hopkins to reduce the unnecessary treatment of localized prostate cancer has led to the acceptance of active surveillance as a standard of care approach to the management of favorable risk disease.
For his outstanding contributions in the field of prostate cancer, specifically in the areas of PSA screening and surveillance, Dr. Carter has been recognized by the American Urological Association with the Urology Care Foundation Distinguished Scholar Alumnus, the Distinguished Contribution Award, the Eugene Fuller Triennial Prostate Award, and the Huggins Medal from the Society of Urologic Oncology.
The AUA Gold Cystoscope Award
Dr. Trinity Bivalacqua received the AUA Gold Cystoscope Award, one of the highest honors awarded by the AUA. It recognizes the young urologist who has made the most contributions during the first 10 years following completion of his residency. Recipients of this Award have a distinguished history of going on to become leaders in the field. Examples of this include the following Brady faculty and former residents: Patrick Walsh, William Catalona, Mani Menon, Herbert Lepor, Louis Kavoussi, Alan Partin, Jeffrey Cadeddu, and William Roberts.
Thank you to the NIH For supporting our researchers like Dr. Pierorazio!
This weeks NIH Loan Repayment Programs Ambassador Network spotlight goes to Dr. Phillip Pierorazio. Dr. Pierorazio is a Clinical Research LRP recipient - funded by National Cancer Institute and a Associate Professor of Urology and Oncology at Johns Hopkins Medicine.
Congratulations Phillip Pierorazio for being inducted into the Johns Hopkins Medicine Distinguished Teaching Society by the JHUSOM student body!
Distinguished Contribution Award for Arthur L. Burnett II, MD, MBA
2018 Awards - 55th Annual AUA Award Winner For outstanding contributions to the fields of prostate cancer, sexual medicine and urologic mentoring.
Dr. Ballentine Carter, awarded Huggins Medal
For contributions and lifetime achievement in research and clinical practice that has contributed to the progress in the treatment for patients with genitourinary neoplasms.
Dr. Alan Partin awarded AUA 2015 Distinguished Service Award
January 22, 2015
For contributions to science, most importantly, the creation of the "Partin tables," which are used by urologists throughout the world.
Dr. Patrick C. Walsh selected Giant of Cancer Care 2014
Exceptional cancer researchers and cancer physicians aren’t born—they’re made. Although they come from varied backgrounds, there is a common thread they all seem to exhibit: a dogged persistence in tackling and solving some of the most complex scientific challenges; a compassionate drive to improve the quality of life of the patient; drawing inspiration from mentors who came before them; and all too often, they have experienced the loss of a family member or friend from cancer. These attributes and experiences mark just some of what makes up an individual destined to thrive in the oncology field. The Giants of Cancer Care initiative celebrates individuals who have achieved landmark success within the field of oncology.